National control requirements for blood products in Australia.
The regulatory processes for therapeutic goods in Australia will be outlined with particular emphasis on the Federal Government's policy toward marketing of blood and related products and its role in the regulation of these therapeutic goods. Aspects which will also be briefly addressed are viral contamination, the need for a code of good manufacturing practice for blood products, traceability, standards and the reporting of problems.
D000163:Acquired Immunodeficiency Syndrome / Q000097:blood / Q000517:prevention & control / Q000635:transmission; D001315:Australia; D001798:Blood Proteins / Q000592:standards*; D006509:Hepatitis B / Q000097:blood / Q000517:prevention & control / Q000635:transmission; D006801:Humans; D007885:Legislation, Pharmacy; D011786:Quality Control
D001798:Blood Proteins